Insmed Inc (INSM): Total Liabilities
$1.53B
As of 2025-12-31
$1.35B
As of 2026-06-30
-0.9%
3-year compound annual growth
+24.0%
5-year compound annual growth
+42.3%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.53B | -12.3% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $1.74B | +4.7% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $1.66B | +5.9% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $1.57B | +88.3% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $833.04M | +60.1% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $520.27M | +8.2% | 2022-02-17, Balance as of period end |
| 2019-12-31 | $480.62M | +21.3% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $396.29M | +292.4% | 2020-02-25, Balance as of period end |
| 2017-12-31 | $100.99M | +21.0% | 2019-02-22, Balance as of period end |
| 2016-12-31 | $83.47M | +86.1% | 2018-02-23, Balance as of period end |
| 2015-12-31 | $44.86M | +0.5% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $44.63M | +34.5% | 2016-02-25, Balance as of period end |
| 2013-12-31 | $33.17M | +1.5% | 2015-02-27, Balance as of period end |
| 2012-12-31 | $32.68M | +487.1% | 2014-03-06, Balance as of period end |
| 2011-12-31 | $5.57M | +62.7% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $3.42M | n/a | 2012-03-13, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Insmed Inc (INSM) | 2025-12-31 | $1.53B | -12.3% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $663.99M | -20.5% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $415.23M | +16.9% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $601.51M | +17.6% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $164.81M | +46.4% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $501.83M | -0.1% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $1.60B | +29.3% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $196.03M | +37.9% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $528.12M | +18.6% |
Compare INSM, OPK, TGTX, AXSM side by side · Screen every company in Pharmaceutical Preparations ↗